Dong Wha Pharm Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dong Wha Pharm Company Limited with three other
companies in this sector in South Korea:
Daewon Pharmaceutical Co Ltd
sales of 240.72 billion Korean Won [US$214.97 million]
of which 99%
KolmarBNH Co Ltd
(256.01 billion Korean Won [US$228.62 million]
of which 90%
was Biotech), and
Samjin Pharmaceutical Company Limited
(239.31 billion Korean Won [US$213.71 million]
of which 100%
Dong Wha Pharm Company Limited reported sales of 237.47 billion Korean Won (US$212.06 million)
December of 2016.
increase of 6.4%
versus 2015, when the company's sales were 223.20 billion Korean Won.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Dong Wha Pharm Company Limited had sales
of 234.56 billion Korean Won.